Related Experiment Video
Updated: Jul 20, 2026
08:15
Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
[Obesity and gastrointestinal motility].
1Institute for Digestive Research, Department of Internal Medicine, Soon Chun Hyang University College of Medicine, Yongsan-gu, Seoul, Korea. joonlee@hosp.sch.ac.kr
Summary
Obesity alters gastrointestinal (GI) motility, affecting digestion and appetite. Understanding these GI motility changes is key for developing effective obesity treatments.
Area of Science:
- Gastroenterology and metabolic disease research.
Context:
- Obesity is linked to significant alterations in gastrointestinal (GI) motility, impacting digestion, nutrient absorption, appetite, and satiety.
- Obese individuals exhibit a higher prevalence of gastroesophageal reflux disease (GERD) and esophageal motor disorders compared to the general population.
Purpose:
- To investigate the specific changes in GI motility patterns observed in obese patients.
- To explore the relationship between altered GI motility, autonomic dysfunction, and appetite regulation in obesity.
- To review current and potential therapeutic strategies for managing GI motility disorders in obesity.
Summary:
- Obese patients often show accelerated gastric emptying of solids and larger fasting gastric volumes.
- Fasting small intestinal contractile activity is more prominent, yet orocecal transit is delayed in obesity.
- Autonomic dysfunction is frequently observed, potentially contributing to increased appetite and delayed satiety.
Impact:
- Findings highlight the complex interplay between obesity and GI function, influencing eating behaviors.
- Identifies potential therapeutic targets for obesity management, including GI hormone modulation.
- Emphasizes the need for further research into the causal relationships and therapeutic interventions for GI motility alterations in obesity.
Related Concept Videos
01:20Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
01:16Gastric Motility
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...